Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia
- PMID: 3977194
- DOI: 10.7326/0003-4819-102-4-466
Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia
Abstract
Erythromelalgia was the presenting symptom in 26 of 40 patients with thrombocythemia in its primary form or when associated with polycythemia vera. The localized painful burning, redness, and warm congestion in the extremities could be accurately documented with thermography. Skin punch biopsy samples taken from the affected areas showed typical arteriolar inflammation, fibromuscular intima proliferation, and thrombotic occlusions. Erythromelalgia often progressed to ischemic acrocyanosis or necrosis in toes or fingers. Complete relief of pain and restoration of microvascular circulation disturbances was obtained with the cyclo-oxygenase inhibitors aspirin and indomethacin, but not with sodium-salicylate or the platelet inhibitors dipyridamole, sulfinpyrazone, ticlopidine, and dazoxiben. The erythromelalgia was alleviated during busulfan-induced remissions of thrombocythemia and its recurrence coincided with relapsing thrombocythemia. These observations suggest a causal relationship between erythromelalgia and thrombocythemia, in which platelet-mediated inflammatory and occlusive arteriolar changes play a part in the etiology of erythromelalgia.
Similar articles
-
Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.Ann Hematol. 2003 Mar;82(3):153-9. doi: 10.1007/s00277-002-0593-x. Epub 2003 Feb 12. Ann Hematol. 2003. PMID: 12634947
-
Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.Pathol Biol (Paris). 2003 Apr;51(3):167-75. doi: 10.1016/s0369-8114(03)00038-5. Pathol Biol (Paris). 2003. PMID: 12781799 Review.
-
Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.Leuk Lymphoma. 1996 Sep;22 Suppl 1:47-56. doi: 10.3109/10428199609074360. Leuk Lymphoma. 1996. PMID: 8951772 Review.
-
Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.Platelets. 2006 Dec;17(8):528-44. doi: 10.1080/09537100600758677. Platelets. 2006. PMID: 17127481
-
Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.Acta Haematol. 2015;133(1):56-63. doi: 10.1159/000360388. Epub 2014 Aug 7. Acta Haematol. 2015. PMID: 25116182
Cited by
-
Dermatologic manifestations of hematologic disorders.Ann Hematol. 2024 Oct;103(10):3889-3903. doi: 10.1007/s00277-024-05761-5. Epub 2024 Apr 25. Ann Hematol. 2024. PMID: 38662204 Review.
-
Primary thrombocythemia: diagnosis, clinical manifestations and management.Ann Hematol. 1993 Aug;67(2):57-62. doi: 10.1007/BF01788127. Ann Hematol. 1993. PMID: 8347730 Review. No abstract available.
-
Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.Thrombosis. 2011;2011:536062. doi: 10.1155/2011/536062. Epub 2011 Jun 8. Thrombosis. 2011. PMID: 22084665 Free PMC article.
-
Coronary vasculopathy in polycythemia vera.Pathol Oncol Res. 1998;4(1):37-9. doi: 10.1007/BF02904693. Pathol Oncol Res. 1998. PMID: 9555119
-
JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.Pathol Oncol Res. 2015 Jul;21(3):751-8. doi: 10.1007/s12253-014-9885-4. Epub 2015 Jan 10. Pathol Oncol Res. 2015. PMID: 25573593 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases